David M. Reese

Companies

• AmgenEVP, Research and Development Aug 2, 2018 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Amgen AMGN42,256 shares²$18.5M at $437.78May 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 7, 2026Shares withheld for tax 556 shares at $331.11 of Amgen²
• May 6, 2026Shares withheld for tax 454 shares at $329.59 of Amgen³
• May 5, 2026Granted 2,912 shares of Amgen³
• May 2, 2026Shares withheld for tax 687 shares at $329.82 of Amgen⁴
• May 2, 2026Shares withheld for tax 746 shares at $329.82 of Amgen⁴
• Mar 16, 2026Shares withheld for tax 6,022 shares at $366.21 of Amgen⁵
• Mar 3, 2026Granted 12,063 shares of Amgen⁶
• Nov 12, 2025Gift 309 shares of Amgen⁷
• Nov 11, 2025Gift 6,490 shares of Amgen⁷
• May 6, 2025Granted 3,549 shares of Amgen⁸
• May 2, 2025Shares withheld for tax 665 shares at $283.78 of Amgen⁹
• May 2, 2025Shares withheld for tax 702 shares at $283.78 of Amgen⁹
• Apr 30, 2025Shares withheld for tax 768 shares at $288.56 of Amgen¹⁰
• Mar 17, 2025Shares withheld for tax 3,635 shares at $313.71 of Amgen¹¹
• Mar 3, 2025Granted 7,277 shares of Amgen¹²
• Feb 21, 2025Sold 25,225 shares at $304.44 of Amgen¹³
• Feb 19, 2025Sold 8,711 shares at $293.22 of Amgen¹³
• Feb 19, 2025Exercised options 8,711 shares at $156.35 of Amgen¹³
• May 7, 2024Granted 3,196 shares of Amgen¹⁴
• May 5, 2024Shares withheld for tax 633 shares at $311.29 of Amgen¹⁵
• May 2, 2024Shares withheld for tax 650 shares at $277.37 of Amgen¹⁶
• Apr 30, 2024Shares withheld for tax 690 shares at $276.38 of Amgen¹⁷
• Mar 18, 2024Shares withheld for tax 6,202 shares at $268.87 of Amgen¹⁸
• Mar 6, 2024Granted 12,407 shares of Amgen¹⁹
• Nov 28, 2023Gift 165 shares of Amgen²⁰